Isa Odidi

Shares of IntelliPharmaCeutics Intl Inc (NASDAQ: IPCI), a micro-cap pharmaceutical company that manufacturers novel and generic controlled-release oral solid dosage drugs, surged higher by more than 15 percent on Thursday. IntelliPharmaCeutics announced that a bioequivalence trial of its...

IntelliPharmaCeutics International Inc. (NASDAQ: IPCI) spiked Tuesday after the company obtained fast-track designation for its Rexista Oxycodone treatment designed to deter abuse. The Ontario-based company said the designation from the U.S. Food and Drug Administration could potentially result...